Gillian Farnie
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Inhibition of MLLT1 Limits Growth of KMT2A::AFF1 Leukemias Without Killing Healthy Hematopoietic Stem Cells.
Journal: Experimental hematology
Published: April 16, 2026
A novel preclinical model of the normal human breast.
Journal: Journal of mammary gland biology and neoplasia
Published: November 24, 2023
Discovery of PFI-6, a small-molecule chemical probe for the YEATS domain of MLLT1 and MLLT3.
Journal: Bioorganic & medicinal chemistry letters
Published: August 31, 2023
PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo.
Journal: Scientific reports
Published: April 05, 2023
RNA-Seq analysis of early transcriptional responses to activation in the leukaemic Jurkat E6.1 T cell line.
Journal: Wellcome open research
Published: June 07, 2021
FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity.
Journal: NPJ breast cancer
Published: June 29, 2020
Peptide gels of fully-defined composition and mechanics for probing cell-cell and cell-matrix interactions in vitro.
Journal: Matrix biology : journal of the International Society for Matrix Biology
Published: March 27, 2019
Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling.
Journal: Nature communications
Published: February 26, 2019
Target Identification Using Chemical Probes.
Journal: Methods in enzymology
Published: November 05, 2018
Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9.
Journal: SLAS discovery : advancing life sciences R & D
Published: October 26, 2018
Discovery of an MLLT1/3 YEATS Domain Chemical Probe.
Journal: Angewandte Chemie (International ed. in English)
Published: September 14, 2018
Last Updated: 09/26/2026